English
Swedish
Home
About DexTech
Analysis
Technology
Clinical Research
Prostate cancer
Investors
Press releases
Contact
Home
About DexTech
Analysis
Technology
Clinical Research
Prostate cancer
Investors
Press releases
Contact
250820 – PR – DexTech Medical’s Myeloma Study, Dose Group 2
20 August, 2025
250820 - PR - DexTech Medical's Myeloma Study, Dose Group 2
«
DexTech Medical’s Myeloma Study, Dose Group 2
We use cookies to ensure that we give you the best experience on our website.
If you continue to use this site we will assume that you are happy with it.
Ok